Allowing several leading laboratories to formulate their own rules under the protection of anti-monopoly exemptions essentially means outsourcing the formulation of public policies to the stakeholders. The direction of independent review is correct, but the review standards, enforcement authority, and participation qualifications must undergo public debate, rather than being determined behind closed doors by a few companies.